Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) has 241 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| Janus Henderson Group Plc | 31 Mar, 2026 | 4,481,926 | 2,551,601 | 132.19% | $314,445,646.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 3,790,557 | 10,936 | 0.29% | $310,370,807.00 |
| Deep Track Capital, LP | 31 Mar, 2026 | 3,600,000 | 595,966 | 19.84% | $252,540,000.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 3,552,612 | -237,945 | -6.28% | $249,215,733.00 |
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 3,346,025 | 10,705 | 0.32% | $234,723,654.00 |
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 3,335,320 | 157,884 | 4.97% | $273,096,002.00 |
| Deep Track Capital, LP | 31 Mar, 2026 | 3,004,034 | 4,034 | 0.13% | $245,970,304.00 |
| Paradigm Biocapital Advisors LP | 31 Mar, 2026 | 2,562,154 | -103,544 | -3.88% | $209,789,170.00 |
| Paradigm Biocapital Advisors LP | 31 Mar, 2026 | 2,562,154 | 0 | 0.00% | $179,735,103.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 2,399,560 | 127,470 | 5.61% | $196,475,972.00 |
| JENNISON ASSOCIATES LLC | 31 Mar, 2026 | 2,230,069 | -374,511 | -14.38% | $182,598,052.00 |
| Morgan Stanley | 31 Mar, 2026 | 2,040,742 | 128,340 | 6.71% | $167,095,971.00 |
| Morgan Stanley | 31 Mar, 2026 | 1,944,272 | -96,470 | -4.73% | $136,390,741.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 1,930,325 | 491,326 | 34.14% | $158,062,427.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,760,541 | 1,760,541 | 0.00% | $123,501,951.00 |
| JENNISON ASSOCIATES LLC | 31 Mar, 2026 | 1,712,124 | -517,945 | -23.23% | $120,105,500.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 1,194,377 | 436,271 | 57.55% | $83,785,547.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,188,624 | -1,266,173 | -51.58% | $97,324,533.00 |
| TANG CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,188,624 | 0 | 0.00% | $83,381,974.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 1,172,427 | 141,386 | 13.71% | $95,998,323.00 |